微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-048761 Size: 8 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-044837 Size: 4 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-044423 Size: 8 KB 网页链接
$Myomo(MYO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-014267 Act: 34 Size: 7 MB 网页链接
$Myomo(MYO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-014246 Act: 34 Size: 872 KB 网页链接
$Myomo(MYO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-210141 Act: 33 Size: 355 KB 网页链接
$Myomo(MYO)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001193125-22-210144 Act: 33 Size: 470 KB 网页链接
$Myomo(MYO)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001193125-22-210150 Act: 34 Size: 683 KB 网页链接
$Myomo(MYO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-22-012519 Act: 34 Size: 218 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-040760 Size: 8 KB 网页链接